আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
grazax frostþurrkuð tungurótartafla 75.000 sq-t
alk-abelló a/s - phleum pratense - frostþurrkuð tungurótartafla - 75.000 sq-t
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
lemtrada
sanofi belgium - alemtuzumab - margvísleg sclerosis - valdar ónæmisbælandi lyf - lemtrada er ætlað fullorðnum sjúklingum með endurtekna endurtekna mænusigg (rrms) með virkum sjúkdómum sem eru skilgreindar með klínískum eða hugsanlegum eiginleikum.
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
syntocinon (syntocinon 40 a.e./ml) nefúði, lausn 6,7 míkróg/skammt
alfasigma s.p.a. - oxytocinum inn - nefúði, lausn - 6,7 míkróg/skammt
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
tritanrix hepb
glaxosmithkline biologicals s.a. - diphtheria toxoid, hepatitis b surface antigen, bordetella pertussis (inactivated), tetanus toxoid - hepatitis b; tetanus; immunization; whooping cough; diphtheria - bóluefni - tritanrix hepb er ætlað til virkrar bólusetningar gegn barnaveiki, stífkrampa, kíghósta og lifrarbólgu b (hbv) hjá ungbörnum frá sex vikum (sjá kafla 4.
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
solu-cortef stungulyfsstofn og leysir, lausn 100 mg
pfizer aps - hydrocortisonum natríumsúkkínat - stungulyfsstofn og leysir, lausn - 100 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
solu-cortef stungulyfsstofn og leysir, lausn 250 mg
pfizer aps - hydrocortisonum natríumsúkkínat - stungulyfsstofn og leysir, lausn - 250 mg
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
ervebo
merck sharp & dohme b.v. - skal læknir hafa blöðrum bólgur veira (álag indiana) með eyðingu umslagið glýkóprótein, komi með zaire ebolavirus (álag kikwit 1995) yfirborðið glýkóprótein - blæðandi hiti, ebóla - bóluefni - ervebo is indicated for active immunization of individuals 1 year of age or older to protect against ebola virus disease (evd) caused by zaire ebola virus. notkun ervebo ætti að vera í samræmi við opinbera tillögur.
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
nexviadyme
sanofi b.v. - avalglucosidase alfa - glycogen geymsluskammt tegund ii - Önnur meltingarvegi og efnaskipti vörur, - nexviadyme (avalglucosidase alfa) is indicated for long-term enzyme replacement therapy for the treatment of patients with pompe disease (acid α-glucosidase deficiency).
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
nicotinell mint munnsogstafla 2 mg
haleon denmark aps - nicotinum bítartrat - munnsogstafla - 2 mg